Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ... Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
REFERENCES Maraganore D. M., Lesnick T. G., Elbaz A., Chartier-Harlin M. C., Gasser T., Krüger R., Hattori N., 216 Mellick G. D., Quattrone A., Satoh J., Toda T., Wang J., Ioannidis J. P., de Andrade M., Rocca W.A.; UCHL1 Global Genetics Consortium. (2004) UCHL1 is a Parkinson's disease susceptibility gene. Ann. Neurol. 55, 512–521. Marek K., Jennings D. and Seibyl J. (2002) Do dopamine agonists or levodopa modify Parkinson’s disease progression? Eur. J. Neurol. 9, 15–22. Markesbery W. R., Ehmann W. D., Hossain T. I., Alauddin M. and Goodin D. T. (1981) Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging. Ann. Neurol. 10, 511–516. Markesbery W. R., Ehmann W. D., Alauddin M. and Hossain T. I. (1984) Brain trace element concentrations in aging. Neurobiol. Aging 5, 19–28. Markey S. P., Johannessen J. N., Chiueh C. C., Burns R. S. and Herkenham M. A. (1984) Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 311, 464–467. Markwell M. A., Haas S. M., Bieber L. L. and Tolbert N. E. (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206–210. Marongiu R., Spencer B., Crews L., Adame A., Patrick C., Trejo M., Dallapiccola B., Valente E. M. and Masliah E. (2009) Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. J. Neurochem. 108, 1561–1574. Marsden C. D. (1983) Neuromelanin and Parkinson's disease. J. Neural Transm. Suppl. 19, 121– 141. Marshansky V. N., Novgorodov S. A. and Yaguzhinsky L. S. (1983) The role of lipid peroxidation in the induction of cation transport in rat liver mitochondria. The antioxidant effect of oligomycin and dicyclohexylcarbodiimide. FEBS Lett. 158, 27–30.
REFERENCES Marti M. J., James C.J., Oo T. F., Kelly W. J. and Burke R. E. (1997) Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J. Neurosci. 17, 2030–2039. Martin R. B. (1986) The chemistry of aluminum as related to biology and medicine. Clin. Chem. 32, 1797–1806. Martin R. B. (1997) Chemistry of aluminum in the central nervous system, in Mineral and Metal Neurotoxicology (Yasui M., Strong M. J., Ota K. and Verity M. A., eds), Vol. 80, pp. 75–80. CRC Press, Boca Raton, Florida. Martinez-Martin P., Gil-Nagel A., Gracia L. M., Gomez J. B., Martinez-Sarries J. and Bermejo F. (1994) Unified Parkinson’s Disease Rating Scale characteristics and structure. Mov. Disord. 9, 76–83. Martinez-Vicente M., Talloczy Z., Kaushik S., Massey A. C., Mazzulli J., Mosharov E. V., Hodara R., Fredenburg R., Wu D. C., Follenzi A., Dauer W., Przedborski S., Ischiropoulos H., Lansbury P. T., Sulzer D. and Cuervo A. M. (2008) Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest. 118, 777–788. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A. and Mucke L. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265–1269. Mattson M. P. (2000) Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1, 120–129. Mayeux R. (2003) Epidemiology of neurodegeneration. Annu. Rev. Neurosci. 26, 81–104. Mazzulli J. R., Mishizen A. J., Giasson B. I., Lynch D. R., Thomas S. A., Nakashima A., Nagatsu T., Ota A. and Ischiropoulos H. (2006) Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. J. Neurosci. 26, 10068–10078. 217
- Page 189 and 190: RESUMEN zonas cerebrales excepto en
- Page 191: CONCLUSIONES
- Page 194 and 195: CONCLUSIONES Capítulo 2 4) La admi
- Page 196 and 197: CONCLUSIONES 172 En base a las conc
- Page 199 and 200: Publications as a direct result fro
- Page 201: REFERENCES
- Page 204 and 205: REFERENCES Agil A., Duran R., Barre
- Page 206 and 207: REFERENCES Baquet Z. C., Bickford P
- Page 208 and 209: REFERENCES 184 1,2,3,6-tetrahydropy
- Page 210 and 211: REFERENCES 186 compacta of the subs
- Page 212 and 213: REFERENCES Chung K. K., Dawson V. L
- Page 214 and 215: REFERENCES Davies K. J. (2001) Degr
- Page 216 and 217: REFERENCES Dhillon A. S., Tarbutton
- Page 218 and 219: REFERENCES Ekstrand M. I., Falkenbe
- Page 220 and 221: REFERENCES Fleming S. M., Delville
- Page 222 and 223: REFERENCES Ghribi O., Dewitt D. A.,
- Page 224 and 225: REFERENCES Good P. F., Olanow C. W.
- Page 226 and 227: REFERENCES Hamilton E. I., Miniski
- Page 228 and 229: REFERENCES Hirsch E. C., Brandel J.
- Page 230 and 231: REFERENCES Inden M., Kitamura Y., T
- Page 232 and 233: REFERENCES Johnson V. J. and Sharma
- Page 234 and 235: REFERENCES Kim W. G., Mohney R. P.,
- Page 236 and 237: REFERENCES Kuhn W., Winkel R., Woit
- Page 238 and 239: REFERENCES 214 K.D. and Polymeropou
- Page 242 and 243: REFERENCES McCord J. M. and Fridovi
- Page 244 and 245: REFERENCES Miu A. C. and Benga O. (
- Page 246 and 247: REFERENCES Nair V. D., McNaught K.,
- Page 248 and 249: REFERENCES Onyango I. G. (2008) Mit
- Page 250 and 251: REFERENCES Perez F. A. and Palmiter
- Page 252 and 253: REFERENCES Przedborski S. and Goldm
- Page 254 and 255: REFERENCES Rifat S. L., Eastwood M.
- Page 256 and 257: REFERENCES Rymar V. V., Sasseville
- Page 258 and 259: REFERENCES Savory J., Herman M. M.
- Page 260 and 261: REFERENCES Shimizu H., Mori T., Koy
- Page 262 and 263: REFERENCES 238 the generation of hy
- Page 264 and 265: REFERENCES Taylor G. A., Moore P. B
- Page 266 and 267: REFERENCES Um J. W., Stichel-Gunkel
- Page 268 and 269: REFERENCES Vila M. and Przedborski
- Page 270 and 271: REFERENCES Whitehead M. W., Farrar
- Page 272 and 273: REFERENCES Yokel R. A. (2002a) Alum
- Page 274: REFERENCES Zhou W., Zhu M., Wilson
REFERENCES<br />
Maraganore D. M., Lesnick T. G., Elbaz A., Chartier-Harl<strong>in</strong> M. C., Gasser T., Krüger R., Hattori N.,<br />
216<br />
Mellick G. D., Quattrone A., Satoh J., Toda T., Wang J., Ioannidis J. P., de Andrade M., Rocca<br />
W.A.; UCHL1 Global Genetics Consortium. (2004) UCHL1 is a Park<strong>in</strong>son's disease<br />
susceptibility gene. Ann. Neurol. 55, 512–521.<br />
Marek K., Jenn<strong>in</strong>gs D. and Seibyl J. (2002) Do dopam<strong>in</strong>e agonists or levodopa modify<br />
Park<strong>in</strong>son’s disease progression? Eur. J. Neurol. 9, 15–22.<br />
Markesbery W. R., Ehmann W. D., Hossa<strong>in</strong> T. I., Alaudd<strong>in</strong> M. and Good<strong>in</strong> D. T. (1981)<br />
Instrumental neutron activation analysis <strong>of</strong> bra<strong>in</strong> alum<strong>in</strong>um <strong>in</strong> Alzheimer disease and<br />
ag<strong>in</strong>g. Ann. Neurol. 10, 511–516.<br />
Markesbery W. R., Ehmann W. D., Alaudd<strong>in</strong> M. and Hossa<strong>in</strong> T. I. (1984) Bra<strong>in</strong> trace element<br />
concentrations <strong>in</strong> ag<strong>in</strong>g. Neurobiol. Ag<strong>in</strong>g 5, 19–28.<br />
Markey S. P., Johannessen J. N., Chiueh C. C., Burns R. S. and Herkenham M. A. (1984)<br />
Intraneuronal generation <strong>of</strong> a pyrid<strong>in</strong>ium metabolite may cause drug-<strong>in</strong>duced<br />
park<strong>in</strong>sonism. Nature 311, 464–467.<br />
Markwell M. A., Haas S. M., Bieber L. L. and Tolbert N. E. (1978) A modification <strong>of</strong> the Lowry<br />
procedure to simplify prote<strong>in</strong> determ<strong>in</strong>ation <strong>in</strong> membrane and lipoprote<strong>in</strong> samples. Anal.<br />
Biochem. 87, 206–210.<br />
Marongiu R., Spencer B., Crews L., Adame A., Patrick C., Trejo M., Dallapiccola B., Valente E. M.<br />
and Masliah E. (2009) Mutant P<strong>in</strong>k1 <strong>in</strong>duces mitochondrial dysfunction <strong>in</strong> a neuronal cell<br />
model <strong>of</strong> Park<strong>in</strong>son's disease by disturb<strong>in</strong>g calcium flux. J. Neurochem. 108, 1561–1574.<br />
Marsden C. D. (1983) Neuromelan<strong>in</strong> and Park<strong>in</strong>son's disease. J. Neural Transm. Suppl. 19, 121–<br />
141.<br />
Marshansky V. N., Novgorodov S. A. and Yaguzh<strong>in</strong>sky L. S. (1983) The role <strong>of</strong> lipid peroxidation<br />
<strong>in</strong> the <strong>in</strong>duction <strong>of</strong> cation transport <strong>in</strong> rat liver mitochondria. The antioxidant effect <strong>of</strong><br />
oligomyc<strong>in</strong> and dicyclohexylcarbodiimide. FEBS Lett. 158, 27–30.
Change language